Water load test before and after PPI-Therapy in patients with gastroesophageal reflux disease

2006 ◽  
Vol 38 ◽  
pp. S132-S133
Author(s):  
E. Battaglia ◽  
M. Grassini ◽  
M. Navino ◽  
P. Niola ◽  
C. Verna ◽  
...  
2017 ◽  
Vol 23 (1) ◽  
pp. 55-63 ◽  
Author(s):  
Katarzyna Rerych ◽  
Józef Kurek ◽  
Ewa Klimacka-Nawrot ◽  
Barbara Błońska-Fajfrowska ◽  
Antoni Stadnicki

Radiology ◽  
2007 ◽  
Vol 243 (2) ◽  
pp. 329-339 ◽  
Author(s):  
Mark E. Baker ◽  
David M. Einstein ◽  
Brian R. Herts ◽  
Erick M. Remer ◽  
Gaspar Alberto Motta-Ramirez ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-6 ◽  
Author(s):  
Li-na Meng ◽  
Shanshan Chen ◽  
Jiande D. Z. Chen ◽  
Hai-feng Jin ◽  
Bin Lu

Objective. To investigate effects and possible mechanisms of transcutaneous electrical acustimulation (TEA) performed by a wearable watch-size stimulator for refractory gastroesophageal reflux disease (RGERD).Methods. Twenty patients diagnosed as RGERD were enrolled in the study and randomly divided into four groups: esomeprazole group (Group A), esomeprazole combined with TEA group (Group B), esomeprazole combined with sham-TEA group (Group C), and esomeprazole combined with domperidone group (Group D). HRM and 24 h pH-impedance monitoring and GerdQ score were used to measure related indexes before and after treatment.Results. (1) TEA significantly increased LESP, compared with PPI treatment only or PPI plus sham-TEA. After pairwise comparison, LESP of Group B was increased more than Group A (P=0.008) or Group C (P=0.021). (2) PPI plus TEA decreased not only the number of acid reflux episodes but also the number of weak acid reflux episodes (P=0.005). (3) Heartburn and reflux symptoms were improved more with PPI + TEA than with PPI treatment only or PPI plus sham-TEA (GerdQ scores,P=0.001).Conclusion. TEA can improve symptoms in RGERD patients by increasing LESP and decreasing events of weak acid reflux and acid reflux; addition of TEA to esomeprazole significantly enhances the effect of TEA.


2007 ◽  
Vol 39 (12) ◽  
pp. 1052-1056 ◽  
Author(s):  
E. Battaglia ◽  
M. Grassini ◽  
M. Navino ◽  
P. Niola ◽  
C. Verna ◽  
...  

2013 ◽  
Vol 2013 ◽  
pp. 1-7 ◽  
Author(s):  
Ying Chen ◽  
Feng Wang ◽  
Yuanxi Jiang ◽  
Chen Wang ◽  
Liwen Yao ◽  
...  

Gastroesophageal reflux disease is a diversity disease that affects life quality of people in the world. Due to the complicated pathogenesis and variations in clinical manifestations, there is still no true gold standard for GERD diagnosis, and it is still difficult to diagnose this disease in some patients. The proton pump inhibitor’s diagnostic test (the PPI test) is noninvasive, of low cost, tied to treatment, and widely accepted. Our aim is to evaluate the diagnostic significance of coapplying a rabeprazole test with the SF-36 for GERD in this study. Our study shows that the SF-36 in combination with the rabeprazole test can screen GERD patients and increase the sensitivity and specificity of GERD diagnosis through reference to the change in SF-36 score before and after the treatment (65 in the trial).


2018 ◽  
Vol 6 (3) ◽  
Author(s):  
Qian Liu

<p class="18">Abstract: Objective: To observe the clinical effect of “Chaihu Shugan Powder Zuojin Pill” in the treatment of non-erosive gastroesophageal reflux disease. Methods: Sixty patients with non-erosive gastroesophageal reflux disease were randomly divided into treatment group and control group (30 cases in each group). The patients were treated with “Zaohu Shugan Powder” and “Zangjin Pills” and omeprazole respectively. For 8 weeks, the clinical efficacy and changes in clinical symptoms were observed. Results: The total effective rate was 93.3% in the treatment group and 80.0% in the control group. There was significant difference between the two groups before and after treatment (P &lt;0.05). Conclusion: “Chaihu Shugan Powder Zuojin Pill” can effectively improve the clinical symptoms of non-erosive gastroesophageal reflux disease.</p>


Sign in / Sign up

Export Citation Format

Share Document